IntraClude Intra-Aortic Occlusion Device, REF: ICF100, 10.5 Fr (3.5 mm) X 39.4" (100 cm), Rx Only, Sterile EO The IntraClude intra-aortic occlusion device is indicated for use in patients undergoing cardiopulmonary bypass. The IntraClude intra-aortic occlusion device occludes and vents the ascending aorta when the balloon is inflated.
Published June 19, 2019 · Recall initiated: May 14, 2019
Summary
FDA records medical device Class I recall Z-1705-2019, published June 19, 2019 and initiated May 14, 2019. Recalling firm: Edwards Lifesciences, LLC; Status: Terminated; Reported quantity: 6552; Lot: All lot numbers. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Possibility of balloon rupture in intra-aortic occlusion devices. If the balloon bursts during cardiopulmonary bypass, the heart can fill and warm, the operative site may be obscured, and the device will need to be exchanged or operative strategy would need to change, including placement of an external cross-clamp, conversion to an open procedure, or performing the procedure under fibrillation.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Edwards Lifesciences, LLC
- Distributor
- Worldwide Distribution: US (nationwide) to states of: UT, GA, NJ, CA, OH, PA, AL, FL, TN, TX, ME, MA, IN, MS, NY, VA, MI, IL, CO, OR, WA, SC, AZ, SD, MO, CT, OK, NV, WV, WI, NC, MN, KY; and countries of: United Arab Emirates, Austria, Australia, Belgium, Canada, Switzerland, Colombia, Czech Republic, Germany, France, United Kingdom, Italy, Netherlands, Poland, Romania, and Sweden.
- Lot
- All lot numbers.
- Risk classification
- Class I
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAGeneric Name: Edwards Commander M Delivery System Generic Name: Edwards Commander M Delivery SystemNovember 11, 2026
- FDAEdwards EVOQUE tricuspid delivery system REF:9850TDS Sterile EOMay 20, 2026
- FDABrand Name: FEM-FLEX II Product Name: Femoral Arterial Cannula Model/Catalog Number: FEMII016AS SoftwareJuly 16, 2025
- FDABrand Name: Optisite Arterial Cannula Product Name: Optisite Arterial Cannula Model/Catalog Number: OPTI16July 16, 2025
- FDAPerformance Mushrooms product is dried mushroom blend of 4 different mushroom mycelial biomass powdersJune 19, 2019
- FDAPrestige II, Prestige SI, Prestige VH Prestige system is a new multi-purpose conventional and digital R/FJune 19, 2019
Questions about this recall
Was IntraClude Intra-Aortic Occlusion Device, REF: ICF100, 10.5 Fr (3.5 mm) X 39.4" (100 cm), Rx Only, Sterile EO The IntraClude intra-aortic occlusion device is indicated for use in patients undergoing cardiopulmonary bypass. The IntraClude intra-aortic occlusion device occludes and vents the ascending aorta when the balloon is inflated. recalled?
Yes. FDA published recall Z-1705-2019 on June 19, 2019. Reported hazard: Possibility of balloon rupture in intra-aortic occlusion devices. If the balloon bursts during cardiopulmonary bypass, the heart can fill and warm, the operative site may be obscured, and the device will need to be exchanged or operative strategy would need to change, including placement of an external cross-clamp, conversion to an open procedure, or performing the procedure under fibrillation.
What should I do if I have this product?
Voluntary: Firm initiated · Letter